Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL299P is a truncated copy of the 7SL RNA gene, categorized as a pseudogene dispersed in the human genome, resulting from reverse transcription of 7SL RNA back into DNA[5][6]. Most 7SL RNA-like sequences in human DNA are pseudogenes, not functional genes; only a handful genuinely encode the signal recognition particle RNA required for co-translational protein targeting[5][6]. RN7SL299P itself does not produce functional RNA or protein, does not participate in signal transduction, cell cycle control, or other biological processes, and is not recognized as a molecular target in therapeutic or pharmacological contexts[1][5][6]. There is no evidence suggesting RN7SL299P is involved in disease, modulates pathology, or is utilized as a biomarker. If a therapeutic or functional role is required, refer to the authentic 7SL RNA gene (not pseudogenes like RN7SL299P)[3][4]. In summary: RN7SL299P is an annotated genomic pseudogene with no known biological, therapeutic, or diagnostic relevance. It is not a receptor, enzyme, transporter, or recognized drug target, and its presence in the genome is largely attributed to retrotransposition events from 7SL RNA[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 299, pseudogene (RN7SL299P).